Larimar Therapeutics Inc (LRMR)
6.57
+0.24
(+3.79%)
USD |
NASDAQ |
Sep 27, 16:00
6.57
0.00 (0.00%)
After-Hours: 20:00
Larimar Therapeutics Cash from Investing (Quarterly): -63.49M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -63.49M |
March 31, 2024 | -68.36M |
December 31, 2023 | -2.629M |
September 30, 2023 | -46.43M |
June 30, 2023 | -9.838M |
March 31, 2023 | 92.25M |
December 31, 2022 | -52.23M |
September 30, 2022 | -3.384M |
June 30, 2022 | -35.34M |
Date | Value |
---|---|
March 31, 2022 | 0.00 |
December 31, 2021 | 6.49M |
September 30, 2021 | -6.791M |
June 30, 2021 | 19.22M |
March 31, 2021 | 5.251M |
December 31, 2020 | -23.54M |
September 30, 2020 | -0.008M |
June 30, 2020 | 41.42M |
March 31, 2020 | -0.778M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-68.36M
Minimum
Mar 2024
92.25M
Maximum
Mar 2023
-8.234M
Average
-3.006M
Median
Cash from Investing (Quarterly) Benchmarks
PTC Therapeutics Inc | -65.92M |
Voyager Therapeutics Inc | -35.94M |
Solid Biosciences Inc | -5.176M |
Design Therapeutics Inc | 27.33M |
Prime Medicine Inc | 6.894M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -13.99M |
Cash from Financing (Quarterly) | -0.334M |
Free Cash Flow | -43.22M |
Free Cash Flow Per Share (Quarterly) | -0.2235 |
Free Cash Flow Yield | -12.82% |